NET PROFIT (x1000 DKK)
EMPLOYEES
Vicore Pharma Holding AB
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
318
|
1,864
|
4 |
Earnings before taxes |
-192,990
|
-215,765
|
-109,184 |
EBITDA |
-192,029
|
-211,755 | |
Total assets |
225,868
|
328,058
|
301,293 |
Current assets |
180,283
|
274,805
|
242,987 |
Current liabilities |
30,934
|
47,678
|
32,829 |
Equity capital |
193,175
|
278,721
|
262,751 |
- share capital |
27,347
|
26,089
|
18,593 |
Employees (average) |
21
|
16
|
13 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency |
85.5%
|
85.0%
|
87.2% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-85.3%
|
-65.2%
|
-36.2% |
Current ratio |
582.8%
|
576.4%
|
740.2% |
Return on equity (ROE) |
-99.9%
|
-77.4%
|
-41.6% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
5
|
3
|
5 |
Chg. No. of employees % |
31%
|
23%
|
63% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.